SCS Annual Conference, London

Company CEO Dr Cath O’Neill is to present "Topical Probiotics, Innovative Therapies for Skin Health and Well-Being" in London on Wednesday 4th of July 2018 at 10.00 am.


SkinBioTherapeutics will be attending and/or presenting at the following events;

Shares and AJ Bell Investor Evening, London

SkinBioTherapeutics to present in London on Wednesday 20th June 2018.

Click here for more information.


Global Group UK Investor Show, London

SkinBioTherapeutics will be exhibiting at the UK Investor Show on the 21st of April at the Queen Elizabeth II Centre in London.

Click here for more information.


Global Engage, Microbiome R&D and Business Collaboration Forum, Rotterdam, The Netherlands

Company CEO Dr Cath O'Neill is to present at the 5th European Microbiome R&D and Business Collaboration Forum which will be held on March 21-22, 2018 in Rotterdam, the Netherlands.

Click here for more information.


Pharmabiotics 2018 Conference, Paris

CEO Dr Cath O'Neill to showcase SkinBioTherapeutics plc in Paris on Thursday 15th March.

Click here for more information.


Shares Investor Evening, Edinburgh

CEO Dr Cath O'Neill to present in Edinburgh on Wednesday 28 February.

For any media enquires, please contact skinbio@instinctif.com

Click here for more information

Click here for the presentation.


Shares Investor Evening, Manchester

CFO Doug Quinn to present in Manchester on Wednesday 21 February.

For any media enquires, please contact skinbio@instinctif.com

Click here for more information

Click here for the presentation.


Wellcome Genome Campus

September 2017 at the Wellcome Genome Campus, Hinxton, Cambridge - 'Exploring human host-microbiome interactions in health and disease'.

Click here for more information


Dermatological Research

September 2017 - The European Society for Dermatological Research meeting in Salzburg.

Click here for more information


Beneficial Microbes Conference

October 2017 - The Beneficial Microbes Conference in Amsterdam.

Click here for more details


Contact Us